NCT00791193 A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IR Status COMPLETED Phase PHASE1
NCT00791167 A Study of the Dose Proportionality of Extended Release Paliperidone Status COMPLETED Phase PHASE1
NCT00790777 A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville Status COMPLETED Phase PHASE1
NCT00790192 Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. Status COMPLETED Phase PHASE3
NCT00789906 Development of Population Norms of the Computerized Neuropsychological Assessment for Effectiveness of the Antipsychotic Treatment in Schizophrenia Status UNKNOWN Phase N/A
NCT00789022 Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment Status UNKNOWN Phase N/A
NCT00784238 Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic Participants Status COMPLETED Phase PHASE4
NCT00783120 Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia Status COMPLETED Phase NA
NCT00781794 Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic Patients Status WITHDRAWN Phase PHASE1
NCT00780884 Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients Status COMPLETED Phase NA
NCT00779506 Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR) Status COMPLETED Phase PHASE4
NCT00774085 An Observational Study to Assess Treatment & Outcomes Data in Patients Receiving Long-Acting Injectable Risperidone Status COMPLETED Phase N/A
NCT00772005 Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia Status COMPLETED Phase PHASE2
NCT00770237 Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without Schizophrenia Status COMPLETED Phase NA
NCT00768612 Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of Schizophrenia Status WITHDRAWN Phase PHASE2
NCT00763438 Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia Status COMPLETED Phase PHASE4